# Ascend Wellness Holdings, Inc. (AAWH) — Financial Analysis

**Exchange:** OTC  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-03  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/AAWH/thesis · /stocks/AAWH/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: AAWH
step: 04
title: Financial Quality & Adversarial Sweep
date: 2026-06-03
---

### Step 04 — Financial Quality & Adversarial Research Sweep: Ascend Wellness Holdings (AAWH)

#### Financial Statement Quality Assessment [S1]

##### Income Statement Quality

AAWH's GAAP income statement requires significant adjustment to be analytically useful due to IRC §280E. Key adjustments:

| Item | GAAP Treatment | Adjustment Needed | Notes |
|------|---------------|-------------------|-------|
| Revenue | Clean — recognized on dispensary sales/wholesale delivery | None | Reliable |
| Cost of Revenue | Includes only COGS (cultivation/production); cannot deduct SG&A | None — COGS only | 280E means SG&A must stay above the line |
| Gross Profit | Clean | None | Comparable across years |
| G&A / SG&A | Full operating expense | None — but compare to Adj. EBITDA | Non-deductible for 280E purposes |
| Income Tax | Paid on gross profit, not net income (280E) | Remove for economic analysis | $45–51M/yr is non-economic tax drag |
| Net Income | Severely distorted by 280E | Use Adj. EBITDA instead | Not comparable to non-cannabis peers |

**Conclusion:** Revenue and Gross Profit are clean metrics. Adj. EBITDA is the primary measure of economic performance. Net income/EPS are structurally impaired by 280E and should not be used for valuation or trend analysis.

##### Balance Sheet Quality

| Item | Assessment |
|------|-----------|
| Cash ($60.9M at Q1'26) | Reliable; confirmed in 10-Q filings |
| Goodwill ($58.4M) | Moderate — accumulated from acquisitions; no impairment recorded recently |
| Inventory (~$50–60M est.) | Cannabis inventory; subject to state destruction/expiration risk; typically conservative |
| Long-Term Debt ($318.9M) | Senior secured notes at 9.5% due July 2029; well-documented in 10-K |
| Lease Obligations | Significant — cannabis companies cannot own real estate under federal law; all locations are leased |
| Negative Equity ($(76.6)M) | Driven by cumulative 280E tax losses, not economic value destruction; total assets still $872M |

**Key balance sheet flag:** Stockholders' equity turned negative in Q4 2025. This is primarily a GAAP accounting artifact of 280E — the company has been paying taxes on gross profit for years while reporting net losses, depleting retained earnings. It does not mean the business is economically worthless (assets of $872M vs. liabilities of $948M). However, it does create covenant risk and limits refinancing flexibility.

##### Cash Flow Quality

| Item | FY2024 | FY2025 | Notes |
|------|--------|--------|-------|
| Operating Cash Flow | ~$63M est. | ~$38M | Declining but positive |
| Capex | ~$20M | ~$26M | Organic expansion |
| Free Cash Flow | ~$43M est. | ~$12M | Declining sharply |
| FCF as % of Adj. EBITDA | ~37% | ~10% | Compression trend |

FCF compression is concerning — interest expense (~$51M/yr) now exceeds annual FCF ($12M). The company is consuming cash on an economic basis despite positive Adj. EBITDA. If revenue continues to decline without cost reduction, FCF could turn negative in FY2026.

---

#### Adversarial Research Sweep [S2]

*Note: No earnings transcripts used; adversarial research conducted via web search, SEC filings review, and public records.*

##### Short Interest / Bearish Theses

**Primary bear thesis circulating in public forums:**
1. **Revenue decline is structural, not cyclical.** Bear argument: Illinois and Michigan are permanently oversupplied markets; Ohio is now also trending toward over-licensing. Revenue recovery is not assured.
2. **Leverage is unsustainable.** Net debt of $216M vs. $12M FCF means the company cannot service debt from operations at current trajectory. If FCF turns negative, AAWH may need to raise dilutive equity.
3. **Schedule III rescheduling could disappoint.** The rescheduling process has been through multiple delays; bears argue 280E elimination may be later than market expects or get tied up in legal challenges.
4. **Negative equity creates covenant risk.** Senior note covenants may be tested if EBITDA declines further; technical default risk is non-trivial.
5. **OTC listing limits institutional ownership.** AAWH cannot uplift to Nasdaq/NYSE while cannabis remains federally illegal, keeping a large buyer pool permanently on the sidelines.

##### Investigations, Lawsuits, Controversies

**SEC/Regulatory investigations:** No material SEC enforcement actions identified in filings or public records search. [S2: 10-K FY2024 — Legal Proceedings; web search]

**Class action lawsuits:** No active securities class action lawsuits identified. Historical: AAWH settled routine commercial disputes in 2022–2023 (details in 10-K legal proceedings note; amounts not material).

**$17M Arbitration Reserve (FY2025):** AAWH disclosed a $17M arbitration reserve in FY2025 related to a commercial dispute. This was resolved in Q1 2026. Not a going-concern event. [S3: Q1 2026 PR — "resolution of $17M arbitration reserve"]

**Management turnover:** CEO and CFO were both replaced in August 2024 — significant change within 12 months. New CEO: Samuel Brill (previously EVP Strategy). New CFO: Roman Nemchenko (internal promotion from CAO). Leadership transitions create execution risk during a period of industry headwinds. [S4: Governance file]

**Auditor change (March 2025):** Macias Gini dismissed; WithumSmith+Brown appointed. Auditor changes are a yellow flag; no accounting restatements identified. Withum is a reputable mid-market auditor with cannabis sector expertise. [S5: SEC 8-K — March 2025]

**Dual-class share structure:** Founders retain super-voting rights through a dual-class structure. CEO Abner Kurtin (chair/co-founder) and co-founder Frank Perullo control significant voting power disproportionate to economic stake. This creates governance risk but is standard in the cannabis sector. [S6: Governance file]

##### Cannabis-Specific Compliance Risks

| Risk | Status |
|------|--------|
| State license compliance | No disclosed license revocations; routine renewals ongoing |
| DEA/DOJ enforcement | De minimis risk under current federal policy (enforcement deprioritized for compliant state operators) |
| Track-and-trace compliance | Required in all AAWH states; company uses standard compliance systems |
| Multi-state licensing continuity | Ongoing regulatory requirement; no disclosed failures |

---

#### Accounting Adjustments for Analysis

The most important adjustments for analyzing AAWH:
1. **Remove 280E income tax from all comparative analysis** — use Adj. EBITDA, not GAAP net income.
2. **Add back non-cash lease expense** where relevant (cannabis leases are significant and non-standard).
3. **Treat goodwill ($58M) as potentially impaired** if any state licenses are lost — goodwill is largely license-acquisition premium.
4. **FCF = Operating Cash Flow - Capex** is the most reliable near-term cash generation signal.

---

#### Thesis Tracker Update

Step 04 confirms the bear case thesis is primarily execution-risk based (revenue decline, leverage) and catalyst-timing based (280E rescheduling delay). The bull case is that the discount (~2.1x EV/EBITDA vs. 4–5x peers) overcompensates for these risks given: (a) debt is refinanced to 2029 with no near-term maturity, (b) $116M Adj. EBITDA provides a real earnings cushion, (c) 280E elimination could add $45–50M in after-tax cash flow. The auditor change and management turnover are yellow flags, not red flags.

---

#### Source Index

| Code | Source |
|------|--------|
| S1 | SEC XBRL + 10-K FY2024 — financial statement analysis |
| S2 | 10-K FY2024 — Legal Proceedings; web search for short reports |
| S3 | Q1 2026 Earnings Press Release — arbitration resolution |
| S4 | proxy/governance_and_compensation.md — management changes |
| S5 | SEC EDGAR 8-K search — auditor change disclosure |
| S6 | proxy/governance_and_compensation.md — dual-class structure |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AAWH/fundamental

## Navigation

- Overview: /stocks/AAWH
- Financials (this page): /stocks/AAWH/financials
- Thesis: /stocks/AAWH/thesis
- Investment Memo: /stocks/AAWH/memo
- Coverage universe: /stocks